Moxifloxacin and Ketorolac Tromethamine Eye Drops

MOXIASE-KT Eye Drops contain Moxifloxacin and Ketorolac Tromethamine and belong to the ophthalmic, anti-infective, and ocular anti-inflammatory segments.  Moxifloxacin is an antibiotic used in the eye against certain bacterial infections, and Ketorolac Tromethamine is an anti-inflammatory medicine which is used in ophthalmic care to help manage eye inflammation and related discomfort in suitable cases. 

For PCD pharma franchise partners, ophthalmic distributors, wholesalers, and pharma entrepreneurs, MOXIASE-KT can be added to an ophthalmology-focused product portfolio. 

Moreover, Godase Healthcare offers MOXIASE-KT in a convenient 5 ml eye-drop pack, making it a useful addition to a broader ophthalmic product range.

Product Highlights:

• Brand Name: MOXIASE-KT
• Product: Moxifloxacin + Ketorolac Eye Drops
• Dosage Form: Ophthalmic Solution
• Therapeutic Segment: Ophthalmology / Eye Care
• Product Category: Ophthalmic Anti-infective + NSAID
• Packing: 5 ml
• Target Partners: PCD Pharma Franchise Partners, Ophthalmic Distributors, Wholesalers & Pharma Entrepreneurs

PCD Franchise for Moxifloxacin and Ketorolac Tromethamine Eye Drops – Godase Healthcare

Godase Healthcare offers Moxifloxacin and Ketorolac Tromethamine Eye Drops for a PCD franchise business opportunity under its brand name MOXIASE-KT. This product is suitable for pharma businesses that are looking to expand their ophthalmic and eye-care product portfolio. Additionally, this combination eye drop can be added to an ophthalmology-focused range, which allows PCD partners to offer an ophthalmic product along with other eye-care medicines in their territory. 

By adding this eye care drop to your portfolio, you can expand into the ophthalmology segment and build a more diverse range of pharmaceutical products. Territory availability, pricing, MOQ, product supply, franchise rights, and other commercial terms may vary and should be confirmed directly with Godase Healthcare.

Key Business Advantages of MOXIASE-KT

• Expand into Eye Care: Add an ophthalmic product to your existing pharma portfolio.
• Combination Formulation: Combines Moxifloxacin + Ketorolac for anti-infective and anti-inflammatory ophthalmic use.
• Ophthalmology Portfolio: A suitable addition for partners focusing on eye-care products.
• Diversify Your Range: Helps new and existing pharma entrepreneurs expand across different therapeutic segments.
• Specialised Dosage Form: Eye drops offer a distinct product category for distributors with suitable ophthalmic distribution channels.

Disclaimer: MOXIASE-KT is a prescription eye-care product. The content provided here is for general product and business information and should not replace professional medical advice. Use the product only as directed by a qualified ophthalmologist or healthcare professional.